ImmunityBio
IBRX
IBRX
130 hedge funds and large institutions have $84.1M invested in ImmunityBio in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 11 closing their positions.
Holders
130
Holders Change
+14
Holders Change %
+12.07%
% of All Funds
2.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
33
Reduced
30
Closed
11
Calls
$4.51M
Puts
$4.7M
Net Calls
-$190K
Net Calls Change
-$2.05M
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$24.8M |
2 |
AC
2
Armistice Capital
New York
|
$5.87M |
3 |
3
BlackRock
New York
|
$18.3M |
4 |
CS
4
Credit Suisse
Zurich,
Switzerland
|
$2.59M |
5 |
![]()
5
Group One Trading
Chicago,
Illinois
|
$755K |